• Images
• Videos
• Documents
• Books
• Articles

History

It was founded by Alphabet Inc. subsidiary Verily Life Sciences and British pharmaceutical company GlaxoSmithKline (GSK) in November 2016.²³ The partnership to form the company was announced on 1 August 2016.⁴

Verily has a 45% equity interest, while GSK has a 55% equity interest, making GSK the effective owner.⁵ The initial agreed upon investment between the two companies is up to £540 million over a period of seven years⁶⁷ and will be used "to develop prototype devices aimed at controlling a variety of chronic conditions."⁸ Additionally, both companies agreed to contribute their existing intellectual property rights.

In November 2021, a team of laparoscopic surgeons successfully completed the first implantation of a Galvani device in a patient. ⁹

External links

• Announcement by GSK

References

1. Kollewe, Julia (28 August 2017). "Electroceuticals: the 'bonkers' gamble that could pay off for GlaxoSmithKline". the Guardian. Retrieved 3 August 2018. https://www.theguardian.com/business/2017/aug/28/electroceuticals-bioelectronics-implants-glaxosmithkline-galvani-kris-famm ↩

2. "Galvani Bioelectronics Website". Galvani Bioelectronics. Retrieved 24 December 2016. http://www.galvani.bio/ ↩

3. "Galvani Bioelectronics". Verily Life Sciences website. Retrieved 24 December 2016. https://verily.com/projects/interventions/galvani-bioelectronics/index.html ↩

4. Temperton, James (1 August 2016). "GSK and Google just created a £540m bioelectronic health firm". Wired. Retrieved 24 December 2016. https://www.wired.co.uk/article/galvani-bioelectronics-gsk-google-alphabet-verily ↩

5. Temperton, James (1 August 2016). "GSK and Google just created a £540m bioelectronic health firm". Wired. Retrieved 24 December 2016. https://www.wired.co.uk/article/galvani-bioelectronics-gsk-google-alphabet-verily ↩

6. Temperton, James (1 August 2016). "GSK and Google just created a £540m bioelectronic health firm". Wired. Retrieved 24 December 2016. https://www.wired.co.uk/article/galvani-bioelectronics-gsk-google-alphabet-verily ↩

7. "Bioelectric Medicine Market Focusing Long-Term Professional Industry and Making New Commitments to the Sustainable Future". Worldanalytics24.com. 23 January 2019. Retrieved 31 January 2019. https://worldanalytics24.com/bioelectric-medicine-market-focusing-long-term-professional-industry-and-making-new-commitments-to-the-sustainable-future-2018-2026/23817/ ↩

8. "Galvani Bioelectronics". FierceBiotech. Retrieved 13 July 2020. https://www.fiercebiotech.com/special-report/fiercemedicaldevices-2016-fierce-15-galvani-bioelectronics ↩

9. "Verily Life Sciences". verily.com. Retrieved 15 February 2017. https://verily.com/blog/galvani-bioelectronics-reaches-major-milestone-in-ra-neuromodulation-therapy-with-first-patient-implantation/ ↩